-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on PTC Therapeutics, Raises Price Target to $106

Benzinga·07/31/2026 14:38:53
語音播報
Wells Fargo analyst Benjamin Burnett maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $93 to $106.